NXEN 0.02 Nexien BioPharma, Inc.
| Range: | 0.011-0.048 | Vol Avg: | 13140 | Last Div: | 0 | Changes: | 0 |
| Beta: | 0.99 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Wed Nov 29 2017 | Empoloyees: | |||
| CUSIP: | 65343D100 | CIK: | 0001625288 | ISIN: | US65343D1000 | Country: | US |
| CEO: | Mr. Richard S. Greenberg | Website: | https://www.nexienbiopharma.com | ||||
Nexien BioPharma, Inc. operates as a pharmaceutical company. It focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, and pre-clinical and clinical pathways for the treatment of various diseases, medical conditions, and disorders. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow